Defining the critical period of hedgehog pathway inhibitor‐induced cranial base dysplasia in mice

Background The hedgehog signaling pathway is critical for developmental patterning of the limb, craniofacial and axial skeleton. Disruption of this pathway in mice leads to a series of structural malformations, but the exact role and critical period of the Hh pathway in the early development of the...

Full description

Saved in:
Bibliographic Details
Published in:Developmental dynamics Vol. 250; no. 4; pp. 527 - 541
Main Authors: Chen, Jiangping, Tang, Wenbing, Lin, Chengquan, Hong, Yuhang, Mao, Chuanqing, Lai, Yongzhen, Liao, Caiyu, Lin, Minkui, Chen, Weihui
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-04-2021
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The hedgehog signaling pathway is critical for developmental patterning of the limb, craniofacial and axial skeleton. Disruption of this pathway in mice leads to a series of structural malformations, but the exact role and critical period of the Hh pathway in the early development of the cranial base have been rarely described. Results Embryos exposed to vismodegib from E7.5, E9.5, and E10.5 had a higher percentage of cranial base fenestra. The peak incidence of hypoplasia in sphenoid winglets and severe craniosynostosis in cranial base synchondroses was observed when vismodegib was administered between E9.5 and E10.5. Cranial base craniosynostosis results from accelerating terminal differentiation of chondrocytes and premature osteogenesis. Conclusions We define the critical periods for the induction of cranial base deformity by vismodegib administration at a meticulous temporal resolution. Our findings suggest that the Hh pathway may play a vital role in the early development of the cranial base. This research also establishes a novel and easy‐to‐establish mouse model of synostosis in the cranial base using a commercially available pathway‐selective inhibitor. Key Findings Embryos exposed to vismodegib to E7.5,E9.5 and E10.5 caused diverged cranial base phenotype. Treatment of vismodegib at E9.5 and E10.5 can lead to hypoplasia in sphenoid winglets, cranial base fenestra and severe craniosynostosis in cranial base. The cranial base craniosynostosis result from premature differentiation and osteogenesis of synchondrosis.
Bibliography:Funding information
Open subject project of Fujian Provincial Oral Biomaterial Engineering Technology Research Center /Fujian Provincial Key Laboratory of Stomatology, Grant/Award Number: 2019kq07; Natural Science Foundation of Fujian Province, Grant/Award Numbers: 2018J01823, 2019J02011; Texas A&M University
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1058-8388
1097-0177
DOI:10.1002/dvdy.270